Patents by Inventor Gregory Stoloff

Gregory Stoloff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
    Publication number: 20240100002
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Application
    Filed: November 14, 2023
    Publication date: March 28, 2024
    Applicant: Infirst Healthcare Limited
    Inventors: Robin M. Bannister, John Brew, Wilson Caparros Wanderley, Gregory A. Stoloff, Suzanne J. Dilly, Gemma Szucs, Olga Pleguezuelos Mateo
  • Recombinant Nucleic Acid Construct Encoding Influenza Peptides and Compositions
    Publication number: 20230233660
    Abstract: The present specification discloses recombinant nucleic acid constructs encoding an immunogenic multiepitope polypeptide comprising two or more polypeptides, recombinant nucleic acid constructs encoding at least two epitopes from two or more internal proteins of influenza virus, compositions comprising such recombinant nucleic acid constructs and methods of eliciting a T cell immune response against an influenza virus in a vertebrate using such recombinant nucleic acid constructs and compositions.
    Type: Application
    Filed: September 9, 2022
    Publication date: July 27, 2023
    Applicant: PepTcell Limited
    Inventors: Gregory A. Stoloff, Wilson Romero Caparros-Wanderley
  • Influenza peptides and compositions
    Patent number: 11439702
    Abstract: The present specification discloses recombinant nucleic acid constructs encoding an immunogenic multiepitope polypeptide comprising two or more polypeptides, recombinant nucleic acid constructs encoding at least two epitopes from two or more internal proteins of influenza virus, compositions comprising such recombinant nucleic acid constructs and methods of eliciting a T cell immune response against an influenza virus in a vertebrate using such recombinant nucleic acid constructs and compositions.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: September 13, 2022
    Assignee: PepTcell Limited
    Inventors: Gregory A. Stoloff, Wilson Romero Caparros-Wanderley
  • Cancer Drug and Uses
    Publication number: 20210252024
    Abstract: A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.
    Type: Application
    Filed: May 5, 2021
    Publication date: August 19, 2021
    Applicant: Health Clinics Limited
    Inventors: Robin M. Bannister, John Brew, Gregory A. Stoloff
  • Chagas Antigens and Antibodies and Compositions, Methods and Uses Thereof
    Publication number: 20210220453
    Abstract: The present specification discloses Trypanosoma antigens, immunogenic compositions and medicaments comprising such Trypanosoma antigens, methods and uses for such Trypanosoma antigens and immunogenic compositions for treating a Trypanosoma-based disease.
    Type: Application
    Filed: April 3, 2021
    Publication date: July 22, 2021
    Applicant: PepTcell Limited
    Inventors: Olga Pleguezuelos Mateo, Wilson Caparros-Wanderley, Gregory A. Stoloff
  • Cancer drug and uses
    Patent number: 11026956
    Abstract: A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.
    Type: Grant
    Filed: May 30, 2018
    Date of Patent: June 8, 2021
    Assignee: Health Clinics Limited
    Inventors: Robin M. Bannister, John Brew, Gregory A. Stoloff
  • Chagas antigens and antibodies and compositions, methods and uses thereof
    Patent number: 10973897
    Abstract: The present specification discloses Trypanosoma antigens, immunogenic compositions and medicaments comprising such Trypanosoma antigens, methods and uses for such Trypanosoma antigens and immunogenic compositions for treating a Trypanosoma-based disease.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: April 13, 2021
    Assignee: PepTcell Limited
    Inventors: Olga Pleguezuelos Mateo, Wilson Caparros-Wanderley, Gregory A. Stoloff
  • Influenza Peptides and Compositions
    Publication number: 20200397889
    Abstract: The present specification discloses recombinant nucleic acid constructs encoding an immunogenic multiepitope polypeptide comprising two or more polypeptides, recombinant nucleic acid constructs encoding at least two epitopes from two or more internal proteins of influenza virus, compositions comprising such recombinant nucleic acid constructs and methods of eliciting a T cell immune response against an influenza virus in a vertebrate using such recombinant nucleic acid constructs and compositions.
    Type: Application
    Filed: September 4, 2020
    Publication date: December 24, 2020
    Applicant: PepTcell Limited
    Inventors: Gregory A. Stoloff, Wilson Romero Caparros-Wanderley
  • Influenza peptides and compositions
    Patent number: 10765734
    Abstract: The present specification discloses recombinant nucleic acid constructs encoding an immunogenic multiepitope polypeptide comprising two or more polypeptides, recombinant nucleic acid constructs encoding at least two epitopes from two or more internal proteins of influenza virus, compositions comprising such recombinant nucleic acid constructs and methods of eliciting a T cell immune response against an influenza virus in a vertebrate using such recombinant nucleic acid constructs and compositions.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: September 8, 2020
    Assignee: PepTcell Limited
    Inventors: Gregory A. Stoloff, Wilson Romero Caparros-Wanderley
  • Compositions and methods for treating chronic inflammation and inflammatory diseases
    Patent number: 10653778
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: May 19, 2020
    Assignee: Infirst Healthcare Limited
    Inventors: Robin M. Bannister, John Brew, Wilson Caparros-Wanderely, Suzanne J. Dilly, Olga Pleguezeulos Mateo, Gregory A. Stoloff
  • Influenza Peptides and Compositions
    Publication number: 20190365883
    Abstract: The present specification discloses recombinant nucleic acid constructs encoding an immunogenic multiepitope polypeptide comprising two or more polypeptides, recombinant nucleic acid constructs encoding at least two epitopes from two or more internal proteins of influenza virus, compositions comprising such recombinant nucleic acid constructs and methods of eliciting a T cell immune response against an influenza virus in a vertebrate using such recombinant nucleic acid constructs and compositions.
    Type: Application
    Filed: August 14, 2019
    Publication date: December 5, 2019
    Applicant: PepTcell Limited
    Inventors: Gregory A. Stoloff, Wilson Romero Caparros-Wanderley
  • Influenza Peptides and Compositions
    Publication number: 20190201519
    Abstract: The present specification discloses recombinant nucleic acid constructs encoding an immunogenic multiepitope polypeptide comprising two or more polypeptides, recombinant nucleic acid constructs encoding at least two epitopes from two or more internal proteins of influenza virus, compositions comprising such recombinant nucleic acid constructs and methods of eliciting a T cell immune response against an influenza virus in a vertebrate using such recombinant nucleic acid constructs and compositions.
    Type: Application
    Filed: March 7, 2019
    Publication date: July 4, 2019
    Applicant: PepTcell Limited
    Inventors: Gregory A. Stoloff, Wilson Romero Caparros-Wanderley
  • Peptide sequences and compositions
    Patent number: 10335480
    Abstract: The present specification discloses recombinant nucleic acid constructs encoding an immunogenic multiepitope polypeptide comprising two or more polypeptides, recombinant nucleic acid constructs encoding at least two epitopes from two or more internal proteins of influenza virus, compositions comprising such recombinant nucleic acid constructs and methods of eliciting a T cell immune response against an influenza virus in a vertebrate using such recombinant nucleic acid constructs and compositions.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: July 2, 2019
    Assignee: PepTcell Limited
    Inventors: Gregory A. Stoloff, Wilson Romero Caparros-Wanderley
  • Peptide sequences and compositions
    Patent number: 10279032
    Abstract: The present specification discloses recombinant nucleic acid constructs encoding an immunogenic multiepitope polypeptide comprising two or more polypeptides, recombinant nucleic acid constructs encoding at least two epitopes from two or more internal proteins of influenza virus, compositions comprising such recombinant nucleic acid constructs and methods of eliciting a T cell immune response against an influenza virus in a vertebrate using such recombinant nucleic acid constructs and compositions.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: May 7, 2019
    Assignee: PepTcell Limited
    Inventors: Gregory A. Stoloff, Wilson Romero Caparros-Wanderley
  • Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
    Publication number: 20190091334
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Application
    Filed: November 30, 2018
    Publication date: March 28, 2019
    Applicant: Infirst Healthcare Limited
    Inventors: Robin M. Bannister, John Brew, Wilson Caparros-Wanderely, Suzanne J. Dilly, Olga Pleguezeulos Mateo, Gregory A. Stoloff
  • Hygiene Compliance Method, Use and System
    Publication number: 20190046679
    Abstract: The present specification discloses methods of monitoring hygiene compliance, hygiene monitoring systems and methods and uses of such systems.
    Type: Application
    Filed: August 12, 2018
    Publication date: February 14, 2019
    Applicant: Skylark Indicators Limited
    Inventors: Gregory A. Stoloff, Robin M. Bannister
  • Cancer drug and uses
    Patent number: 10188668
    Abstract: A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.
    Type: Grant
    Filed: March 6, 2017
    Date of Patent: January 29, 2019
    Assignee: Health Clinics Limited
    Inventors: Robin M. Bannister, John Brew, Gregory A. Stoloff
  • Compositions and methods for treating chronic inflammation and inflammatory diseases
    Patent number: 10155042
    Abstract: The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
    Type: Grant
    Filed: June 5, 2017
    Date of Patent: December 18, 2018
    Assignee: Infirst Healthcare Limited
    Inventors: Robin M. Bannister, John Brew, Wilson Caparros-Wanderely, Suzanne J. Dilly, Olga Pleguezeulos Mateo, Gregory A. Stoloff
  • Modulators of androgen synthesis
    Patent number: 10111877
    Abstract: The present specification discloses compositions comprising at least one therapeutic compound capable of modulating androgen production and methods and uses for treating a disorder associated with androgen production using such compositions and/or compounds.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: October 30, 2018
    Assignee: Tangent Reprofiling Limited
    Inventors: Suzanne Dilly, Gregory Stoloff, Paul Taylor
  • Cancer Drug and Uses
    Publication number: 20180271883
    Abstract: A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a lipid or other building block of a cell membrane or organelle, and/or cholesterol. The pharmaceutical composition can comprise one or more cancer therapeutics that can be administered individually or in combination to an individual.
    Type: Application
    Filed: May 30, 2018
    Publication date: September 27, 2018
    Applicant: Health Clinics Limited
    Inventors: Robin M. Bannister, John Brew, Gregory A. Stoloff